Coca-Cola Europacific Partners heads into its Q1 2026 results with short sellers steadily rebuilding positions after a sharp reduction in late March — making the direction of travel as notable as the level.
Short interest has climbed every session since late March. It reached 1.1% of the free float on April 28, up from a trough of 0.9% on March 27 — a 23% increase in under five weeks. The move is slow and consistent rather than aggressive, but the directionality is clear: shorts have been adding into the recent price softness. Borrowing costs remain modest at 0.52% APR, barely changed over the month, so this is not a borrow-driven squeeze setup. Borrow availability is comfortably loose, with lending market utilisation running near 6% — well below the 52-week peak of 19% — meaning there is no scarcity in the lending pool.
The stock itself dropped 3% on Tuesday to €81.30, pulling the one-week loss to just over 1%. That follows a flat-to-slightly-positive month, so the day-before-earnings slip stands out. Most close peers moved in the opposite direction — CCH rose 1.7% on the day, ABI gained 1.9%, and added nearly 4% — making CCEP's underperformance into the print a clear divergence rather than a sector-wide move.
The ownership picture adds a layer of stability to the backdrop. The two anchor shareholders — COBEGA and The Coca-Cola Company — together hold roughly 55% of shares outstanding and reported no change in their positions at the most recent filings. Among active managers, Invesco and MFS have both added materially in recent months. On the insider side, the CFO and a chief-level officer each sold shares on March 13 at prices near €101, well above current levels; one independent director subsequently bought 1,250 shares in late March around €81.60, a modest vote of confidence close to where the stock trades today. Analyst data is too stale to be reliable, so no price-target comparison is meaningful here.
The valuation backdrop is quietly firming: the trailing P/E has risen roughly 0.5 points over the past 30 days to around 18.3x, while EV/EBITDA has nudged up to nearly 12x. The earnings history carries a mixed signal — the two events logged in early 2026 both produced small negative day-one moves of under 1%, while the February 2026 full-year release prompted a 5% jump followed by an 8% five-day run. Today's Q1 print is therefore less a test of whether CCEP can grow and more a question of whether the company can sustain the margin and volume momentum that drove February's reaction, at a moment when shorts are quietly rebuilding and the stock is lagging its peers into the open.
See the live data behind this article on ORTEX.
Open CCEP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
